Navigation Links
Synthetic platelet maker receives innovator award
Date:9/30/2010

A Case Western Reserve University researcher will receive a $2.3 million New Innovator Award today to further develop and broaden the uses of synthetic platelets and the technology that makes them work.

Erin Lavik, associate professor of biomedical engineering, uses nanotechnology to build platelets of biodegradable polymers, which link with natural platelets to stem bleeding faster.

She and fellow researchers initially pursued the technology after seeing the damage and death tolls among soldiers who received traumatic brain injuries in Afghanistan and Iraq.

The award, presented by the National Institutes of Health, is designed specifically to support unusually creative new investigators with highly innovative research ideas at an early stage of their career.

"It will provide a wonderful foundation for supporting my students as we pursue this research," Lavik said.

Lavik's lab will continue testing and fine-tuning the artificial platelets toward use in people suffering all kinds of traumatic injuries. She also plans to develop new modes of drug delivery based on the system the synthetic platelets use to home in and lock onto clotting natural platelets.

"NIH is pleased to be supporting early-stage investigators from across the country who are taking considered risks in a wide range of areas in order to accelerate research," said Francis S. Collins, M.D., Ph.D., director of the National Institutes. "We look forward to the results of their work."


'/>"/>

Contact: Kevin Mayhood
kevin.mayhood@case.edu
216-368-4442
Case Western Reserve University
Source:Eurekalert

Page: 1

Related medicine news :

1. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
2. Chemo Plus Synthetic Drug Shrunk Pancreatic Tumors
3. Synthetic eye prosthesis
4. Surf Sweets Among Few Candy Offerings Free of Synthetic Dyes Despite Growing Consumer Concern Over Affect on Children
5. Biosynthetic Corneas Show Promise in Transplants
6. Synthetic lethality strategy improves molecularly targeted cancer therapy
7. Low-Dose Platelet Transfusions Deemed Safe
8. Fewer platelets could be used for some cancer and bone-marrow transplantation patients
9. New York Sports Medicine Offers Platelet Rich Plasma Therapy For Treatment of Injury
10. After Teeth Are Pulled, Platelet-Rich Plasma May Speed Healing
11. Overactive Blood Platelets May Play Role in Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... 2017 , ... TransPixel Volume 2 is a set of transitions that create ... effect isolates horizontal and vertical lines of pixels and sorts their pixels by darkness, ... animation and can be changed using a drop-down menu. Create amazing and artistic transitions ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading ... Horine Chiropractic , directed by Dr. Russell Horine, DC to their exclusive list ... run with Dr. Russell Horine serving as the clinic director and his son Dr. ...
(Date:7/20/2017)... ... July 20, 2017 , ... The Dermatology Clinic announced today the ... his BS in Biology from LSU, graduating summa cum laude. He attended Emory University ... his residency in St. Louis, Dr. Dunbar moved to New York to complete an ...
(Date:7/20/2017)... ... July 20, 2017 , ... With nearly half of ... insurance solution company VisitorsCoverage Inc. has launched TMQuotes, a new cloud-based solution platform ... products online, under their own brand. The online marketplace bridges the technological gap ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017  Sysmex America, Inc., a leading provider ... as well as middleware information systems technology, today ... quality assurance easier and more risk free than ... for the innovation that it delivers to the ... assurance processes to a new level with automated, ...
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... 2017 The Institute for In Vitro Sciences ... recipient of a VITROCELL® inhalation exposure system thanks to ... The device, which is designed to replace animals in ... cells to airborne test materials in an environment that ... system for testing combustible tobacco products, as well as ...
Breaking Medicine Technology: